157 related articles for article (PubMed ID: 25694082)
1. Is Ecto-nucleoside Triphosphate Diphosphohydrolase (NTPDase)-based Therapy of Central Nervous System Disorders Possible?
Roszek K; Czarnecka J
Mini Rev Med Chem; 2015; 15(1):5-20. PubMed ID: 25694082
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors.
al-Rashida M; Iqbal J
Med Res Rev; 2014 Jul; 34(4):703-43. PubMed ID: 24115166
[TBL] [Abstract][Full Text] [Related]
3. Trichomonas vaginalis NTPDase and ecto-5'-nucleotidase hydrolyze guanine nucleotides and increase extracellular guanosine levels under serum restriction.
Menezes CB; Durgante J; de Oliveira RR; Dos Santos VH; Rodrigues LF; Garcia SC; Dos Santos O; Tasca T
Mol Biochem Parasitol; 2016 May; 207(1):10-8. PubMed ID: 27150347
[TBL] [Abstract][Full Text] [Related]
4. Enzyme kinetics and pharmacological characterization of nucleotidases released from the guinea pig isolated vas deferens during nerve stimulation: evidence for a soluble ecto-nucleoside triphosphate diphosphohydrolase-like ATPase and a soluble ecto-5'-nucleotidase-like AMPase.
Mihaylova-Todorova ST; Todorov LD; Westfall DP
J Pharmacol Exp Ther; 2002 Sep; 302(3):992-1001. PubMed ID: 12183656
[TBL] [Abstract][Full Text] [Related]
5. Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities.
Yegutkin GG
Crit Rev Biochem Mol Biol; 2014; 49(6):473-97. PubMed ID: 25418535
[TBL] [Abstract][Full Text] [Related]
6. Ectonucleotidases and nucleotide/nucleoside transporters as pharmacological targets for neurological disorders.
Bonan CD
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):739-50. PubMed ID: 22963442
[TBL] [Abstract][Full Text] [Related]
7. Trichomonas vaginalis nucleoside triphosphate diphosphohydrolase and ecto-5'-nucleotidase activities are inhibited by lycorine and candimine.
Giordani RB; Weizenmann M; Rosemberg DB; De Carli GA; Bogo MR; Zuanazzi JA; Tasca T
Parasitol Int; 2010 Jun; 59(2):226-31. PubMed ID: 20176129
[TBL] [Abstract][Full Text] [Related]
8. Ecto-nucleotidase inhibitors: recent developments in drug discovery.
Baqi Y
Mini Rev Med Chem; 2015; 15(1):21-33. PubMed ID: 25694081
[TBL] [Abstract][Full Text] [Related]
9. Highly Potent and Selective Ectonucleoside Triphosphate Diphosphohydrolase (ENTPDase1, 2, 3 and 8) Inhibitors Having 2-substituted-7- trifluoromethyl-thiadiazolopyrimidones Scaffold.
Afzal S; Zaib S; Jafari B; Langer P; Lecka J; Sévigny J; Iqbal J
Med Chem; 2020; 16(5):689-702. PubMed ID: 31203806
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium inhibition of ecto-nucleoside triphosphate diphosphohydrolase activity in Torpedo electric organ.
Escalada A; Navarro P; Ros E; Aleu J; Solsona C; Martín-Satué M
Neurochem Res; 2004 Sep; 29(9):1711-4. PubMed ID: 15453266
[TBL] [Abstract][Full Text] [Related]
11. Polyoxometalates--a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors.
Müller CE; Iqbal J; Baqi Y; Zimmermann H; Röllich A; Stephan H
Bioorg Med Chem Lett; 2006 Dec; 16(23):5943-7. PubMed ID: 16997558
[TBL] [Abstract][Full Text] [Related]
12. Either the carboxyl- or the amino-terminal region of the human ecto-ATPase (E-NTPDase 2) confers detergent and temperature sensitivity to the chicken ecto-ATP-diphosphohydrolase (E-NTPDase 8).
Mukasa T; Lee Y; Knowles AF
Biochemistry; 2005 Aug; 44(33):11160-70. PubMed ID: 16101300
[TBL] [Abstract][Full Text] [Related]
13. The roles of purinergic signaling in psychiatric disorders.
Cieślak M; Czarnecka J; Roszek K
Acta Biochim Pol; 2016; 63(1):1-9. PubMed ID: 26495439
[TBL] [Abstract][Full Text] [Related]
14. Polyoxometalates--potent and selective ecto-nucleotidase inhibitors.
Lee SY; Fiene A; Li W; Hanck T; Brylev KA; Fedorov VE; Lecka J; Haider A; Pietzsch HJ; Zimmermann H; Sévigny J; Kortz U; Stephan H; Müller CE
Biochem Pharmacol; 2015 Jan; 93(2):171-81. PubMed ID: 25449596
[TBL] [Abstract][Full Text] [Related]
15. Lambda-cyhalothrin exposure alters purine nucleotide hydrolysis and nucleotidase gene expression pattern in platelets and liver of rats.
Aouey B; Fares E; Chtourou Y; Bouchard M; Fetoui H
Chem Biol Interact; 2019 Sep; 311():108796. PubMed ID: 31421116
[TBL] [Abstract][Full Text] [Related]
16. Acidosis is a key regulator of osteoblast ecto-nucleotidase pyrophosphatase/phosphodiesterase 1 (NPP1) expression and activity.
Orriss IR; Key ML; Hajjawi MO; Millán JL; Arnett TR
J Cell Physiol; 2015 Dec; 230(12):3049-56. PubMed ID: 26033523
[TBL] [Abstract][Full Text] [Related]
17. Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases.
Lévesque SA; Lavoie EG; Lecka J; Bigonnesse F; Sévigny J
Br J Pharmacol; 2007 Sep; 152(1):141-50. PubMed ID: 17603550
[TBL] [Abstract][Full Text] [Related]
18. Purine signaling and potential new therapeutic approach: possible outcomes of NTPDase inhibition.
Gendron FP; Benrezzak O; Krugh BW; Kong Q; Weisman GA; Beaudoin AR
Curr Drug Targets; 2002 Jun; 3(3):229-45. PubMed ID: 12041737
[TBL] [Abstract][Full Text] [Related]
19. Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system.
Zimmermann H
Prog Neurobiol; 1996 Aug; 49(6):589-618. PubMed ID: 8912394
[TBL] [Abstract][Full Text] [Related]
20. Leishmania amazonensis: Biological and biochemical characterization of ecto-nucleoside triphosphate diphosphohydrolase activities.
Pinheiro CM; Martins-Duarte ES; Ferraro RB; Fonseca de Souza AL; Gomes MT; Lopes AH; Vannier-Santos MA; Santos AL; Meyer-Fernandes JR
Exp Parasitol; 2006 Sep; 114(1):16-25. PubMed ID: 16603157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
